LYMFOcare: The impact of providing feedback on patients* symptoms and health-related quality of life and offering a self-management website on the self-management of patients with lymphoma. A randomized controlled population-based registry trial.

LYMFOcare: The impact of providing feedback on patients* symptoms and health-related quality of life and offering a self-management website on the self-management of patients with lymphoma. A randomized controlled population-based registry trial. - LYMFOcare

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON42473

Enrollment

500

Registered

2015-10-28

Start date

2016-04-25

Completion date

Unknown

Last updated

2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

haematological malignancy Hodgkin and non-Hodgkin lymphoma

Interventions

Feedback will be provided on quality of life, fatigue, emotional, physical, cognitive and social functioning, physical complaints, anxiety and depressive symptoms, coping and self-management. If pat

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients (men and women) that are newly diagnosed with Hodgkin or non-Hodgkin lymphoma in one of the participating hospitals and were 18 years or older at time of diagnosis.

Exclusion criteria

Exclusion criteria: Unable to complete a Dutch questionnaire. Patients with severe psychopathology or dementia.

Design outcomes

Primary

Measure	Time frame
self-management and psychological distress.	—

Secondary

Measure	Time frame
Anxiety and depression, health care utilization, psychological empowerment, health-related quality of life (HRQoL) generic and specific, symptoms, illness perceptions, personal control, coping, satisfaction with information provision, remoralization, and fatigue.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)